# Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer

> **NCT03904173** · — · ACTIVE_NOT_RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 2300 (actual)

## Conditions studied

- Breast Cancer
- Breast Neoplasms
- Hormone Receptor Positive Tumor

## Interventions

- **DIAGNOSTIC_TEST:** Multi-parameter tests

## Key facts

- **NCT ID:** NCT03904173
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-29
- **Primary completion:** 2027-06
- **Final completion:** 2043-12-31
- **Target enrollment:** 2300 (ACTUAL)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03904173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03904173, "Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03904173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*